Filing Details

Accession Number:
0000937556-14-000144
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2014-12-23 20:52:23
Reporting Period:
2014-12-19
Filing Date:
2014-12-23
Accepted Time:
2014-12-23 20:52:23
Original Submission Date:
2014-12-23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
937556 Masimo Corp MASI Electromedical & Electrotherapeutic Apparatus (3845) 330368882
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1403402 Rick Fishel C/O Masimo Corporation, 52 Discovery
Irvine CA 92618
Pres, Ww Oem Bus & Corp Dev No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-12-19 5,000 $3.33 65,000 No 4 M Direct
Common Stock Disposition 2014-12-19 5,000 $26.85 60,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (Right to Buy) Disposition 2014-12-19 5,000 $0.00 5,000 $3.33
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
56,610 2006-04-14 2015-04-14 No 4 M Direct
Footnotes
  1. The shares covered by this Form 4 were acquired pursuant to a Rule 10b5-1 Sales Plan dated as of June 13, 2014, which is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.
  2. The shares covered by this Form 4 were sold pursuant to a Rule 10b5-1 Sales Plan dated as of June 13, 2014, which is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.
  3. Amendment filed to correct previously filed Form 4 which reported an erroreous exercisable date.
  4. This option was granted on April 14, 2005 and was exercisable as the option vested. This option vested over a five-year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.